Proteomics as a Tool for Understanding Schizophrenia

키워드

참고문헌 (66)

1. Freedman R, "Schizophrenia", N Engl J Med, 349, pp.1738~1749 (2003)
2. Gejman PV, "The role of genetics in the etiology of schizophrenia", Psychiatr Clin North Am, 33, pp.35~66 (2010)
3. Barch DM, "The cognitive neuroscience of schizophrenia", Annu Rev Clin Psychol, 1, pp.321~353 (2005)
4. Miller EK, "An integrative theory of prefrontal cortex function", Annu Rev Neurosci, 24, pp.167~202 (2001)
5. Steriade M, "The functional states of the thalamus and the associated neuronal interplay", Physiol Rev, 68, pp.649~742 (1988)
6. Andreasen NC, "Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging", Science, 266, pp.294~298 (1994)
7. Luu P, "Anterior cingulate cortex regulation of sympathetic activity", Brain, 126, pp.2119~2120 (2003)
8. Benes FM, "Neurobiological investigations in cingulate cortex of schizophrenic brain", Schizophr Bull, 19, pp.537~549 (1993)
9. Carter CS, "Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an eventrelated fMRI study", Am J Psychiatry, 158, pp.1423~1428 (2001)
10. Benes FM, "An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients", Arch Gen Psychiatry, 44, pp.608~616 (1987)
11. Deakin JF, "A two-process theory of schizophrenia: evidence from studies in post-mortem brain", J Psychiatr Res, 31, pp.277~295 (1997)
12. Bogerts B, "Recent advances in the neuropathology of schizophrenia", Schizophr Bull, 19, pp.431~445 (1993)
13. Marini A, "The language of schizophrenia: an analysis of micro and macrolinguistic abilities and their neuropsychological correlates", Schizophr Res, 105, pp.144~155 (2008)
14. Antonova E, "The relationship of structural alterations to cognitive deficits in schizophrenia: a voxel-based morphometry study", Biol Psychiatry, 58, pp.457~467 (2005)
15. Martí-Bonmatí L, "Chronic auditory hallucinations in schizophrenic patients: MR analysis of the coincidence between functional and morphologic abnormalities", Radiology, 244, pp.549~556 (2007)
16. Wilkins MR, "From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis", Biotechnology (NY), 14, pp.61~65 (1996)
17. O'Farrell PH, "High resolution two-dimensional electrophoresis of proteins", J Biol Chem, 250, pp.4007~4021 (1975)
18. Martins-De-Souza D, "Proteome analysis of schizophrenia brain tissue", World J Biol Psychiatry, 11, pp.110~120 (2010)
19. Gygi SP, "Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology", Proc Natl Acad Sci U S A, 97, pp.9390~9395 (2000)
20. Link AJ, "Direct analysis of protein complexes using mass spectrometry", Nat Biotechnol, 17, pp.676~682 (1999)
21. Domon B, "Options and considerations when selecting a quantitative proteomics strategy", Nat Biotechnol, 28, pp.710~721 (2010)
22. Maccarrone G, "Shotgun mass spectrometry workflow combining IEF and LC-MALDITOF", TOF, 2010, pp.29, 99~102
23. Michalski A, "More than 100,000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS", MS, 2011, pp.10, 1785~1793
24. Martins-de-Souza D, "Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia", J Psychiatr Res, 44, pp.1176~1189 (2010)
25. McLoughlin GA, "Analyzing the effects of psychotropic drugs on metabolite profiles in rat brain using 1H NMR spectroscopy", J Proteome Res, 8, pp.1943~1952 (2009)
26. Ditzen C, "Proteomic-based genotyping in a mouse model of trait anxiety exposes disease-relevant pathways", Mol Psychiatry, 15, pp.702~711 (2010)
27. Martins-de-Souza D, "Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia", J Psychiatr Res, 44, pp.989~991 (2010)
28. Martins-de-Souza D, "Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia", J Psychiatr Res, 43, pp.978~986 (2009)
29. Martins-de-Souza D, "Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation", BMC Psychiatry, 9, pp.17~ (2009)
30. Martins-de-Souza D, "Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia", Eur Arch Psychiatry Clin Neurosci, 259, pp.151~163 (2009)
31. Martins-de-Souza D, "Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis", J Neural Transm, 116, pp.275~289 (2009)
32. Kooy FH, "Hyperglycemia in mental disorders", Brain, 42, pp.214~289 (1919)
33. Martins-de-Souza D, "The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics", Antioxid Redox Signal, 5, pp.2067~2079 (2011)
34. Wolkin A, "Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography", Am J Psychiatry, 142, pp.564~571 (1985)
35. Fucetola R, "Age- and dose-dependent glucose-induced increases in memory and attention in schizophrenia", Psychiatry Res, 88, pp.1~13 (1999)
36. Guest PC, "Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients", Mol Psychiatry, 15, pp.118~119 (2010)
37. Kanehisa M, "KEGG: kyoto encyclopedia of genes and genomes", Nucleic Acids Res, 28, pp.27~30 (2000)
38. Bergson C, "Dopamine receptor-interacting proteins: the Ca(2+) connection in dopamine signaling", Trends Pharmacol Sci, 24, pp.486~492 (2003)
39. Greengard P, "The neurobiology of slow synaptic transmission", Science, 294, pp.1024~1030 (2001)
40. Zeng H, "Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working", episodic-like memory, 2001, pp.107, 617~629
41. Seeman P, "Dopamine receptors and the dopamine hypothesis of schizophrenia", Synapse, 1, pp.133~152 (1987)
42. Carlsson A, "Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence", Annu Rev Pharmacol Toxicol, 41, pp.237~260 (2001)
43. Lee JM, "The changing landscape of ischaemic brain injury mechanisms", Nature, 399(6738 Suppl), pp.A7~A14 (1999)
44. Fu Y, "Coherent anti-Stokes Raman scattering imaging of myelin degradation reveals a calcium-dependent pathway in lyso-PtdCho-induced demyelination", J Neurosci Res, 85, pp.2870~2881 (2007)
45. Du Y, "Oligodendrocytes as providers of growth factors", J Neurosci Res, 68, pp.647~654 (2002)
46. Deng W, "Oligodendroglia in developmental neurotoxicity", Neurotoxicology, 24, pp.161~178 (2003)
47. 박해정, "DTI and MTR abnormalities in schizophrenia: Analysis of white matter integrity", NEUROIMAGE, 26, pp.1109~1118
48. Schmitt A, "Petroianu G, et al. Altered thalamic membrane phospholipids in schizophrenia: a postmortem study", Biol Psychiatry, 56, pp.41~45 (2004)
49. Davis KL, "White matter changes in schizophrenia: evidence for myelin-related dysfunction", Arch Gen Psychiatry, 60, pp.443~456 (2003)
50. Honer WG, "Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness", Neuroscience, 91, pp.1247~1255 (1999)
51. Martins de Souza D, "RNA Biomarkers in Schizophrenia, In Biomarkers for Psychiatric Disorders, Vol. 1", pp.97~127 (2009), Springer
52. Martins-de-Souza D, "Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia", J Psychiatr Res, 44, pp.149~156 (2010)
53. Bifulco M, "2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubuleassociated protein and membrane anchor for tubulin", Proc Natl Acad Sci U S A, 99, pp.1807~1812 (2002)
54. Boccaccio GL, "Myelin basic protein mRNA localization and polypeptide targeting", J Neurosci Res, 42, pp.277~286 (1995)
55. Sprinkle TJ, "Assignment of the human 2',3'-cyclic nucleotide 3'-phosphohydrolase gene to chromosome 17", Genomics, 13, pp.877~880 (1992)
56. Peirce TR, "Convergent evidence for 2',3'-cyclic nucleotide 3'-phosphodiesterase as a possible susceptibility gene for schizophrenia", Arch Gen Psychiatry, 63, pp.18~24 (2006)
57. Connor JR, "Iron acquisition and expression of iron regulatory proteins in the developing brain: manipulation by ethanol exposure, iron deprivation and cellular dysfunction", Dev Neurosci, 16, pp.233~247 (1994)
58. Lieberman JA, "Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective", Biol Psychiatry, 46, pp.729~739 (1999)
59. Wojda U, "Calcium ions in neuronal degeneration", IUBMB Life, 60, pp.575~590 (2008)
60. Martins-de-Souza D, "Is the word ‘biomarker' being properly used by proteomics research in neuroscience", Eur Arch Psychiatry Clin Neurosci, 260, pp.561~562 (2010)
61. Benitez-King G, "The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia", Curr Drug Targets CNS Neurol Disord, 3, pp.515~533 (2004)
62. Bernstein HG, "Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy", Expert Rev Neurother, 9, pp.1059~1071 (2009)
63. Steffek AE, "Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia", Schizophr Res, 103, pp.71~82 (2008)
64. Sweitzer SM, "undergoes a GTPdependent conformational change causing vesiculation", Cell, 93, pp.1021~1029 (1998)
65. Dale LB, "Mechanisms of metabotropic glutamate receptor desensitization: role in the patterning of effector enzyme activation", Neurochem Int, 41, pp.319~326 (2002)
66. Ben-Shachar D, "The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia", J Neural Transm, 116, pp.1383~1396 (2009)

관련 논문AI추천